Inactive Instrument
Peregrine Pharmaceuticals Share Price Nasdaq
Stocks
US7136613046
Pharmaceuticals
| Market Cap | 80Cr 70Cr 65Cr 60Cr 112.74Cr 7.66TCr 114.23Cr 777.09Cr 303.5Cr 3.78TCr 299.9Cr 293.44Cr 13TCr | P/E 2023 |
2,007x | P/E 2024 | -3.42x |
|---|---|---|---|---|---|
| Enterprise Value | 96Cr 85Cr 79Cr 72Cr 136.07Cr 9.25TCr 137.87Cr 937.91Cr 366.31Cr 4.57TCr 361.96Cr 354.16Cr 16TCr | EV / Sales 2023 |
8.58x | EV / Sales 2024 | 4.64x |
| Free-Float |
98.58% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2025 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 01/06/2026 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 80Cr | |
| +2.45% | +0.26% | +20.63% | -9.51% | 6.67TCr | |
| -0.08% | +3.28% | +37.43% | +203.98% | 5.33TCr | |
| +1.78% | +54.50% | +54.50% | +54.50% | 4.81TCr | |
| +1.90% | -5.62% | -56.56% | -55.72% | 3.83TCr | |
| -0.23% | +1.18% | +56.48% | -23.02% | 2.99TCr | |
| +1.32% | +3.01% | +69.80% | +90.06% | 2.35TCr | |
| +4.18% | -5.50% | +65.79% | -52.56% | 2.15TCr | |
| +0.35% | +4.51% | +82.58% | +162.70% | 1.65TCr | |
| +1.44% | +0.22% | +64.66% | +126.78% | 1.64TCr | |
| Average | +1.03% | -0.96% | +43.92% | +55.25% | 3.49TCr | |
| Weighted average by Cap. | +1.46% | -0.31% | +34.99% | +50.27% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 145.19Cr 57Cr 706.82Cr 56Cr 55Cr 2.44TCr | 14Cr 12Cr 11Cr 11Cr 20Cr 1.34TCr 20Cr 136.09Cr 53Cr 662.52Cr 53Cr 51Cr 2.29TCr |
| Net income | 6L 5L 5L 4L 8L 5.37Cr 8L 54.47L 21.27L 2.65Cr 21.02L 20.57L 9.17Cr | -14Cr -12Cr -12Cr -11Cr -20Cr -1.35TCr -20Cr -136.91Cr -53Cr -666.51Cr -53Cr -52Cr -2.3TCr |
| Net Debt | 15Cr 13Cr 12Cr 11Cr 21Cr 1.45TCr 22Cr 147.09Cr 57Cr 716.09Cr 57Cr 56Cr 2.48TCr | 17Cr 15Cr 14Cr 12Cr 23Cr 1.59TCr 24Cr 160.81Cr 63Cr 782.88Cr 62Cr 61Cr 2.71TCr |
Employees
-
Sector
Pharmaceuticals
